Cannabotech’s idea is not to replace existing cancer treatments but to enable a patient to have fewer treatments with the same benefit.

Israeli study shows a combination of cannabis and mushrooms can kill a majority of colon cancer cells.

According to statistics, there are going to be over 106,000 new cases of colon cancer that going to be diagnosed this year alone.

Cases of colon cancer have been increasing steadily in the United States since the 1990’s especially among young adults, as this disease usually afflicts the elderly. Generally speaking, the survival rate for colon cancer survivors is just 64% but if it’s diagnosed in a localized stage, the prognosis increases significantly to 91%.

There is a dire need to develop more advanced medical solutions to address the growing colon cancer cases in order to save lives.

IM Cannabis Corp. (the “Company” or “IM Cannabis“) (CSE:IMCC)(NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany is pleased to announce that Focus Medical Herbs Ltd. (“Focus Medical“) has completed the importation of approximately 399 kilograms of premium indoor-grown Canadian dried cannabis from Trichome JWC Acquisition Corp. (“TJAC“), the Company’s wholly-owned Canadian cultivation subsidiary, and an additional supply partner. The launch of this product in the Israeli medical cannabis market by Focus Medical is expected by the end of the first quarter of 2022[1].

A few years ago, Israel overtook Germany as the world’s largest cannabis importer and this is a market that we have been bullish on. 

A core pillar of our bullish view on Israel’s cannabis market is related to how the climate is ideal for cultivating cannabis. When compared to Canada or the United States (US), the cost to cultivate a gram of cannabis is much lower in Israel. As a result, the economics that are associated with cultivating cannabis are much more attractive in Israel and our readers should be aware of this. (Click here to view original article.)

It may be hard to pinpoint the exact time when cannabis will be legalized worldwide, but it’s a safe bet that eventually, most, if not all of the planet, will end cannabis prohibition.

In theory, there could always be a limited amount of countries that stay on the wrong side of history for a very long time. However, most countries will presumably legalize at some point.

Cannabis prohibition is a failed public policy wherever it exists, and that, combined with the economic benefits of a vibrant cannabis industry, is going to influence lawmakers around the globe to step up and end prohibition in their jurisdictions.

During the last year, we have noticed increased interest in the Israeli cannabis market and this is a market that we have been favorable on since inception. The climate in Israel is ideal for cultivating cannabis and we are bullish on the industry due to the economics that are associated with it.

Israel wants to be a little more like Canada.

Prime Minister Binyamin Netanyahu tweeted on Sunday that he will be expunging the criminal records of vast amounts of Israelis who had been caught with cannabis and modelling its budding industry after Canada’s, according to The Jerusalem Post.

“I examined the matter and decided to advance the erasure of criminal records of tens of thousands of Israelis for personal use and possession (of cannabis), something that causes unnecessary suffering to many and is a burden on the courts,” he wrote on the social media site.

In the 55 years since he first isolated D9-tetrahydrocannabinol (better known today as THC) with colleagues Dr. Yehiel Gaoni and Dr. Haviv Edery at Israel’s Weizmann Institute of Science, Dr. Raphael Mechoulam has been the absolute leader in the science of cannabis. He basically started that science from scratch with 5 kilos of Lebanese hash the police donated to his research after Mechoulam’s boss put in the request.

Even all these years later, when Mechoulam talks pot, the cannabis world stops with its ears wide open. This latest announcement from the legendary scientist was no different.

Last month, on the day the cabinet approved the exporting of medicinal cannabis, attorney Yair Geva got the green light for signing a deal with a foreign company, about to be listed on NASDAQ, which intends to invest in an Israeli company, the valuation of which instantly spiked.

Now that the Israeli government has approved cannabis exports, the Tel Aviv Stock Exchange may be getting a new crop of medical-marijuana companies seeking a listing. In contrast to most of the speculative companies already trading on the exchange, the newcomers have a real industry track record.